Works matching IS 15989100 AND DT 2021 AND VI 19 AND IP 4
Results: 16
Gut microbiome and checkpoint inhibitor colitis.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 362, doi. 10.5217/ir.2020.00116
- By:
- Publication type:
- Article
Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 478, doi. 10.5217/ir.2021.00121
- By:
- Publication type:
- Article
Does cytomegalovirus load predict the outcome of acute severe ulcerative colitis?
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 357, doi. 10.5217/ir.2021.00120
- By:
- Publication type:
- Article
Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 398, doi. 10.5217/ir.2020.00107
- By:
- Publication type:
- Article
Hydroxyurea associated ileocecal valve ulcer: evidence for causality.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 468, doi. 10.5217/ir.2020.00099
- By:
- Publication type:
- Article
Crohn's disease at radiological imaging: focus on techniques and intestinal tract.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 365, doi. 10.5217/ir.2020.00097
- By:
- Publication type:
- Article
An overview of the gut side of the SARS-CoV-2 infection.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 379, doi. 10.5217/ir.2020.00087
- By:
- Publication type:
- Article
Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI).
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 386, doi. 10.5217/ir.2020.00080
- By:
- Publication type:
- Article
Pediatric Crohn's disease with severe morbidity manifested by gastric outlet obstruction: two cases report and review of the literature.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 472, doi. 10.5217/ir.2020.00072
- By:
- Publication type:
- Article
Clinical characteristics of inflammatory bowel disease patients with immunoglobulin A nephropathy.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 430, doi. 10.5217/ir.2020.00067
- By:
- Publication type:
- Article
High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 438, doi. 10.5217/ir.2020.00055
- By:
- Publication type:
- Article
Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 461, doi. 10.5217/ir.2020.00042
- By:
- Publication type:
- Article
An elderly woman with severe enteritis mimicking infectious enteritis.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 482, doi. 10.5217/ir.2020.00038
- By:
- Publication type:
- Article
Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 419, doi. 10.5217/ir.2020.00033
- By:
- Publication type:
- Article
Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 448, doi. 10.5217/ir.2020.00026
- By:
- Publication type:
- Article
Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn's disease: 3-year results from a real-world study.
- Published in:
- Intestinal Research, 2021, v. 19, n. 4, p. 408, doi. 10.5217/ir.2020.00025
- By:
- Publication type:
- Article